Drug developers face unique challenges in pediatric rare disease trials, including small and geographically dispersed patient populations, strict ethical limits on sampling and sparse early clinical ...

NINGBO, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global healthcare ...

Lisa Moneymaker, chief strategy officer at Medidata, highlights the role AI will play in clinical development in 2026.

The key market opportunities in the Global In Silico Clinical Trials Market include the potential to significantly cut R&D costs through computer modeling and simulation, thus reducing reliance on ...

Simulation modelling has emerged as a vital tool for understanding and managing the inherent complexity of numerous systems, from healthcare and manufacturing to logistics and business operations. By ...

Clinical trial attrition can be detrimental to clinical outcomes, patient well-being and the financial health of research programs. Clinical trial dropout rates, which range from 15% to 40%, greatly ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies and expansion of site networks, predicts Velocity Clinical Research CEO and ...

Uncovering mechanisms regulating immune system responses is key to strengthening and redirecting them whenever necessary in cancer and infections as well as understanding autoimmune diseases. However, ...

With the Graduate Certificate in Clinical Research Management, you can learn how to best manage and lead clinical research teams while simultaneously ensuring and understanding federal guidelines for ...